Novo Nordisk announced Tuesday that it will cut US list prices of Ozempic and Wegovy by up to 50% starting next year. The ...

Results from ADAPT OCULUS are expected to support a sBLA submission to the FDA to secure a label expansion for oMG.

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online February 18 in eClinicalMedicine.

Clinicians now have an FDA-approved liquid desmopressin option for central diabetes insipidus, designed for dosing consistency across the age spectrum.

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

Those who used menopausal hormone therapy had a 27 to 34% lower mortality hazard than those who did not. HealthDay News — Menopausal hormone therapy is not associated with an increased risk for ...

Maintenance therapy with subcutaneous imsidolimab allowed all treated patients to remain flare-free throughout the GEMINI-2 study period.

Phentolamine ophthalmic solution 0.75% shows significant near vision improvement in patients with presbyopia during the phase 3 VEGA-3 clinical trial.

Most frequent visits among non-mental health conditions addressed by telehealth were for diabetes, HTN, COVID-19 ...

HealthDay News — US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat conditions.

HealthDay News — A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin (AmpR-E) and ceftriaxone resistance (CefR-E) in the United States, according to a study ...

HealthDay News — A new model can predict when someone is likely to develop symptoms of Alzheimer disease (AD) using a single blood test, according to a study published online February 19 in Nature ...